📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model. (2021)

First Author: Ruan JL

Attributed to: OxCD3: Oxford Centre for Drug Delivery Devices funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijrobp.2020.11.046

PubMed Identifier: 33714528

Publication URI: http://europepmc.org/abstract/MED/33714528

Type: Journal Article/Review

Volume: 109

Parent Publication: International journal of radiation oncology, biology, physics

Issue: 5

ISSN: 0360-3016